Skip to content
AdvancedEvidence: Grade Alongevity

Mitochondrial Matrix — Advanced Protocol

Five-compound mitochondrial restoration protocol targeting electron transport chain function (SS-31), mitophagy (Urolithin A), NAD+ synthesis (NMN), membrane stability (Taurine), and exercise mimicry (MOTS-c).

5 steps·5 compounds·Published April 11, 2026

Daily Schedule

Timing and dosage for each step

Morning

20 mg

Subcutaneous injection, 10-20mg/day

Morning

1000 mg

Oral, Mitopure preferred

Morning

500 mg

Sublingual or capsule

Morning

TaurineTier A

4000 mg

Oral powder, 2-4g/day

Pre-exercise

MOTS-cTier B

10 mg

Subcutaneous injection, 2-3x/week, 8 weeks on 4 weeks off

Protocol Overview

Mitochondrial dysfunction is considered one of the primary hallmarks of ageing. As mitochondria decline — accumulating damage, losing membrane potential, and failing to clear dysfunctional units through mitophagy — cellular energy production falls, reactive oxygen species increase, and the cell enters a state of progressive energetic stress.

This protocol addresses mitochondrial health at five distinct points: inner membrane electron transport (SS-31), dysfunctional mitochondria clearance (Urolithin A), NAD+ availability for energy metabolism (NMN), membrane fluidity and stability (Taurine), and exercise-pathway activation (MOTS-c).

The Five-Mechanism Approach

SS-31 (Elamipretide) — a mitochondria-targeted peptide that concentrates in the inner mitochondrial membrane, stabilising cardiolipin — the unique phospholipid required for electron transport chain function. Phase 2 trials in Barth syndrome and heart failure demonstrated significant functional improvement. Animal studies show reversal of age-related mitochondrial decline.

Urolithin A — the only supplement with Phase 2 RCT data demonstrating enhanced mitophagy in humans (Andreux et al., Nature Metabolism, 2019). Urolithin A activates PINK1/Parkin pathway, clearing dysfunctional mitochondria and allowing the pool to be replenished with functional units.

NMN — NAD+ precursor. NAD+ is essential for mitochondrial energy metabolism through the TCA cycle and electron transport chain. Age-related NAD+ decline directly impairs mitochondrial function. NMN rapidly enters cells and raises NAD+ levels within hours.

Taurine — stabilises mitochondrial membrane potential, reduces mitochondrial ROS production, and maintains mitochondrial protein synthesis fidelity. Singh et al. (Science, 2023) identified taurine as a key longevity molecule with mitochondrial mechanisms.

MOTS-c — a mitochondrial-encoded peptide that activates AMPK and FOXO pathways, mimicking the metabolic effects of exercise. Produces systemic metabolic improvements including improved insulin sensitivity and mitochondrial biogenesis.

Dosing Protocol

CompoundDoseTimingRoute
SS-3110–20mg/dayMorningSubcutaneous injection
Urolithin A500–1000mg/dayMorningOral (Mitopure preferred)
NMN500mg/dayMorningOral (sublingual or capsule)
Taurine2–4g/dayMorningOral powder
MOTS-c5–10mg/week2–3x/week, pre-exerciseSubcutaneous injection

MOTS-c cycling: 8 weeks on, 4 weeks off.

Monitoring

Grip strength and VO2max (functional mitochondrial output), CoQ10 serum (mitochondrial health marker), lactate at rest (mitochondrial efficiency), and subjective energy levels on a consistent scale.

Related Research